UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.
A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
12h
News Medical on MSNDysregulation of RNA-binding proteins in rheumatoid arthritis and osteoarthritisAnnouncing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...
Researchers found that maternal morbidity risks were higher among women who underwent in vitro fertilization or intrauterine ...
Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...
27m
AZoLifeSciences on MSNHow Proteins Are Made: From DNA to FunctionProtein synthesis is vital for life, translating genetic information from DNA to functional proteins through transcription ...
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, ...
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...
Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Company’s ...
11h
News Medical on MSNASU researchers propose a unifying explanation for molecular chaos driving Alzheimer's diseaseIn a groundbreaking theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the molecular chaos driving Alzheimer's disease.
21h
News Medical on MSNRUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancerA new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...
Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results